Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.

OBJECTIVE: Long-standing evidence indicates that Alzheimer's disease patients with behavioral symptoms have a worse prognosis and a more rapid disease progression. The current retrospective analysis evaluated the efficacy and safety of memantine in a subpopulation of patients with Alzheimer�...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Wilcock, G, Ballard, C, Cooper, J, Loft, H
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2008

Eitemau Tebyg

Treatment benefits of memantine in moderately severe to severe Alzheimer's disease patients with behavioural symptoms
gan: Wilcock, G, et al.
Cyhoeddwyd: (2006)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
gan: Howard, R, et al.
Cyhoeddwyd: (2012)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
gan: Jones, R, et al.
Cyhoeddwyd: (2009)

Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis
gan: Dominik Glinz, et al.
Cyhoeddwyd: (2019-06-01)

Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials
gan: Ivana Molino, et al.
Cyhoeddwyd: (2013-01-01)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
gan: Wilcock, G
Cyhoeddwyd: (2007)

Donepezil for the treatment of agitation in Alzheimer's disease.
gan: Howard, R, et al.
Cyhoeddwyd: (2007)

Memantine for the treatment of dementia.
gan: Wilcock, G
Cyhoeddwyd: (2003)

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease Reply
gan: Howard, R, et al.
Cyhoeddwyd: (2012)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease
gan: Schneider, L, et al.
Cyhoeddwyd: (2011)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
gan: Schneider, L, et al.
Cyhoeddwyd: (2011)

The clinical use of memantine
gan: Burns, A, et al.
Cyhoeddwyd: (2005)

Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment.
gan: Xiaochuan Wang, et al.
Cyhoeddwyd: (2015-01-01)

Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis
gan: Toshi A Furukawa, et al.
Cyhoeddwyd: (2019-10-01)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
gan: Wilcock, G, et al.
Cyhoeddwyd: (2003)

Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer’s Disease Targeting
gan: Hasan Turkez, et al.
Cyhoeddwyd: (2025-02-01)

Neuroprotective effect of liraglutide and memantine in a rat model of Alzheimer’s disease
gan: Bakhshwin Duaa M., et al.
Cyhoeddwyd: (2024-05-01)

The ECT-AD trial for severe treatment-refractory agitation and aggression in advanced dementia: Scientific rationale and study design
gan: Georgios Petrides, et al.
Cyhoeddwyd: (2025-01-01)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
gan: Farrimond, L, et al.
Cyhoeddwyd: (2012)

Prevalence and correlates of aggressive behaviours occurring in patients with Alzheimer's disease.
gan: Eastley, R, et al.
Cyhoeddwyd: (1997)

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
gan: Wilcock, G, et al.
Cyhoeddwyd: (2002)

Challenges and proposed solutions to conducting Alzheimer’s disease psychosis trials
gan: Clive Ballard, et al.
Cyhoeddwyd: (2024-05-01)

Clozapine to treat aggression and agitation in advanced dementia
gan: A. E. Michael, et al.
Cyhoeddwyd: (2024-04-01)

Neurobiological alteration in agitation in Alzheimer’s disease and possible interventions
gan: Jagadeesh S. Rao, et al.
Cyhoeddwyd: (2024-07-01)

Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).
gan: Ballard, C, et al.
Cyhoeddwyd: (2009)

Memantine for dementia.
gan: Mcshane, R, et al.
Cyhoeddwyd: (2006)

Long term effect of fluoxetine and memantine on biochemical markers of Alzheimer’s disease in scopolamine-induced mice
gan: N. N. H. Istifo, et al.
Cyhoeddwyd: (2023-12-01)

Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients
gan: Ehsan Yaghmaei, et al.
Cyhoeddwyd: (2024-05-01)

Comparing IM Lorazepam and IM Clothiapine for Agitated Psychosis in Hospitalized Patients
gan: •. Kverashvili, et al.
Cyhoeddwyd: (2024-04-01)

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
gan: Wilcock, G, et al.
Cyhoeddwyd: (1982)

Genetic associations with psychosis and affective disturbance in Alzheimer's disease
gan: Inga Margret Antonsdottir, et al.
Cyhoeddwyd: (2024-04-01)

Current situation and prospect of non-drug treatment of agitated symptoms of Alzheimer disease
gan: Zhenfang DONG, et al.
Cyhoeddwyd: (2024-10-01)

Memantine's Role in Refractory Catatonia
gan: Jack Mariani, et al.
Cyhoeddwyd: (2024-11-01)

The use of memantine for depressive symptomatology
gan: J. T. Coelho, et al.
Cyhoeddwyd: (2024-04-01)

Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
gan: Emma D. Frost, et al.
Cyhoeddwyd: (2024-11-01)

THE RELATIONSHIP OF ARGYROPHILIC PLAQUES AND NEUROFIBRILLARY TANGLES TO THE SEVERITY OF DEMENTIA AND CORTICAL CHOLINE ACETYL TRANSFERASE LEVELS IN ALZHEIMERS-DISEASE
gan: Wilcock, G, et al.
Cyhoeddwyd: (1983)

DAILY VARIATIONS IN SLEEP-WAKE PATTERNS AND SEVERITY OF PSYCHOSIS
gan: Waters, F, et al.
Cyhoeddwyd: (2010)

Ketamine for rapid control of hyperactive delirium with severe agitation. A retrospective comparison study
gan: Beatrice Borreani, et al.
Cyhoeddwyd: (2025-03-01)

Healthcare Resource Utilization Among Patients With Agitation in Alzheimer Dementia
gan: Christie Teigland, et al.
Cyhoeddwyd: (2024-10-01)

Development and Validation of a Simple UV–HPLC Method to Quantify the Memantine Drug Used in Alzheimer’s Treatment
gan: Débora Nunes, et al.
Cyhoeddwyd: (2024-09-01)